Prognostic factors for survival after autologous and allogeneic stem cell transplantation for Chronic Lymphocytic Leukemia (CLL): The EBMT experience

被引：0
|
作者：
Michallet, M
Brand, R
Dreger, P
Milligan, DW
Esteve, J
Kimby, E
Gratwohl, A
Apperley, J
Van Biezen, A
Niederwieser, D
机构：
来源：
BONE MARROW TRANSPLANTATION | 2001年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [1] Prognostic factors for survival after autologous stem cell transplantation for chronic lymphocytic leukemia (CLL): The EBMT experience.
    Dreger, P
    van Biezen, A
    Brand, R
    Esteve, J
    Gratwohl, A
    Kimby, E
    Michallet, M
    Milligan, DW
    Niederwieser, D
    [J]. BLOOD, 2000, 96 (11) : 482A - 482A
  • [2] Stem cell transplantation (SCT) for chronic lymphocytic leukemia (CLL):: Outcome and prognostic factors after autologous and allogeneic transplants.
    Esteve, J
    Montserrat, E
    Dreger, P
    Meloni, G
    Pavletic, S
    Catovsky, D
    Dearden, C
    Scimè, R
    Sutton, L
    Michallet, M
    Desablens, B
    Kimby, E
    Coiffier, B
    Brunet, S
    Sanz, MA
    Besalduch, J
    Caballero, D
    Juliusson, G
    Conde, E
    del Potro, E
    Schmitz, N
    [J]. BLOOD, 2001, 98 (11) : 482A - 482A
  • [3] Allogeneic hematopoietic stem cell transplantation (HSCT) for chronic lymphocytic leukemia (CLL): Results and prognostic factors for survival after transplantation. Analysis from EBMT registry.
    Michallet, M
    Brand, R
    Dreger, P
    Millighan, D
    Esteve, J
    Kimby, E
    Apperley, J
    Van Biezen, A
    Niederwieser, D
    [J]. BLOOD, 2000, 96 (11) : 205A - 205A
  • [4] Analysis of prognostic factors on the outcome of autologous and allogeneic stem cell transplantations (SCT) for chronic lymphocytic leukemia (CLL).
    Michallet, M
    Brand, R
    Dreger, P
    Millighan, D
    Esteve, J
    Kimby, E
    Nicolini, F
    Apperley, J
    van Biezen, A
    Niederwieser, D
    [J]. BLOOD, 2001, 98 (11) : 859A - 860A
  • [5] Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia
    Dreger, P
    Montserrat, E
    [J]. LEUKEMIA, 2002, 16 (06) : 985 - 992
  • [6] Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia
    P Dreger
    E Montserrat
    [J]. Leukemia, 2002, 16 : 985 - 992
  • [7] Treatment-related MDS/AML after autologous stem cell transplantation for chronic lymphocytic leukemia (CLL): An EBMT survey.
    Dreger, P
    van Biezen, A
    Brukx, K
    Boogaerts, M
    Michallet, M
    Milligan, D
    Niederwieser, DW
    [J]. BLOOD, 2005, 106 (11) : 326A - 327A
  • [8] Allogeneic and autologous hematopoetic stem cell transplantation for chronic lymphocytic leukemia
    Kulkarni, S
    Powles, R
    Cunningham, D
    Sirohi, B
    Rudin, C
    Saso, R
    Treleaven, J
    Reiley, U
    Singhal, S
    Mehta, J
    Matutes, E
    Catovsky, D
    [J]. BONE MARROW TRANSPLANTATION, 2002, 29 : S165 - S165
  • [9] Allogeneic stem cell transplantation for chronic lymphocytic leukemia (B-CLL).
    Pavletic, ZS
    Bierman, PJ
    Tarantolo, SR
    Vose, JM
    Wu, D
    Reed, EC
    Pierson, JL
    Lynch, J
    Kessinger, A
    Armitage, JO
    Bishop, MR
    [J]. BLOOD, 1997, 90 (10) : 4508 - 4508
  • [10] Prognostic Factors after Nonmyeloablative Allogeneic Stem Transplantation (NST) in Chronic Lymphocytic Leukemia (CLL): Expression of P53 May Not Predict Survival
    Khouri, Issa
    Bassett, Roland L.
    Hsu, Yvonne
    Dickason, Timothy
    Acholonu, Sandra
    Harrell, Robyn
    Okoroji, Grace-Julia
    Silva, Leandro de Padua
    Korbling, Martin J.
    Alousi, Amin M.
    Hosing, Chitra
    Popat, Uday
    Giralt, Sergio A.
    Kebriaei, Partow
    Qazilbash, Muzaffar H.
    Ledesma, Celina
    Keating, Michael J.
    Champlin, Richard E.
    Bueso-Ramos, Carlos
    [J]. BLOOD, 2008, 112 (11) : 412 - 412
12345